A comparative study of prevalence and predictors of metabolic syndrome in various psychiatric disorders in state of Haryana: More than 30 years Vs. less than 30 years. Issue 1 (January 2019)

• Record Type: Journal Article
• Authors: Anjum, Shazia; Bathla, Manish
• Is Part Of: Diabetes & metabolic syndrome. Volume 13:Issue 1(2019)
• Page Start: 510
• Page End: 516
• Publication Date: 2019-01
• Subjects: Diabetes -- Periodicals; Metabolism -- Disorders -- Periodicals; Diabetes Mellitus -- Periodicals; Metabolic Diseases -- Periodicals; Diabète -- Périodiques; Métabolisme, Troubles du -- Périodiques; Endocrinologie -- Périodiques; Diabète -- Physiopathologie -- Périodiques; Diabetes; Metabolism -- Disorders; Electronic journals; Periodicals; 616.462
• DOI: 10.1016/j.dsx.2018.11.002
• Languages: English
• ISSNs: 1871-4021

Abstract

Abstract: Background: Exponential growth of metabolic syndrome in psychiatric disorders is becoming alarming situation to handle with. It is associated with reduced life span of 10–30 years in psychiatric patients attributed to metabolic syndrome, thus needs to be screened and addressed in all psychiatric patients. Objective: the objective of this study was to know the prevalence and its risk factors in various psychiatric disorder and comparing them in older vs younger patients. Methodology: A cross sectional indoor based study was conducted after taking ethical committee approval in 140 patients (substance use disorder, schizophrenia, bipolar and depressive disorders). All the metabolic parameters as per International diabetes federation criteria for metabolic syndrome were assessed involving waist circumference, weight, height, Systolic/diastolic blood pressure, fasting blood sugar, high density lipoprotein and triglycerides. Statistics: Chi square and t -test were used. Results: It was seen that prevalence of metabolic syndrome (MS); 21.4% in psychiatric illness, up to 40% in major depressive disorders, followed by 33% in substance use disorder and 26.7% in psychotic disorders. Prevalence of MS was higher in older patients >30 years group (26% Vs. 16.4% in <30 years group). It was observed that substance use and depressive disorder and high BP in older male patients are all the significant risk factors for metabolic syndrome. Conclusion: More than 1/5th psychiatric patients are affected by metabolic syndrome. Thus, all male psychiatric patients with high BP must be evaluated for metabolic syndrome.